Correlation Between Panaxia Labs and Direct Capital

Can any of the company-specific risk be diversified away by investing in both Panaxia Labs and Direct Capital at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Panaxia Labs and Direct Capital into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Panaxia Labs Israel and Direct Capital Investments, you can compare the effects of market volatilities on Panaxia Labs and Direct Capital and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Panaxia Labs with a short position of Direct Capital. Check out your portfolio center. Please also check ongoing floating volatility patterns of Panaxia Labs and Direct Capital.

Diversification Opportunities for Panaxia Labs and Direct Capital

0.53

Correlation Coefficient

Panaxia Labs  Direct Capital

Very weak diversification

The 3 months correlation between Panaxia and Direct is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Panaxia Labs Israel and Direct Capital Investments in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Direct Capital Inves and Panaxia Labs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Panaxia Labs Israel are associated (or correlated) with Direct Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Direct Capital Inves has no effect on the direction of Panaxia Labs i.e., Panaxia Labs and Direct Capital go up and down completely randomly.

Pair Corralation between Panaxia Labs and Direct Capital

Assuming the 90 days trading horizon Panaxia Labs Israel is expected to generate 1.44 times more return on investment than Direct Capital. However, Panaxia Labs is 1.44 times more volatile than Direct Capital Investments. It trades about 0.07 of its potential returns per unit of risk. Direct Capital Investments is currently generating about 0.06 per unit of risk. If you would invest  1,900  in Panaxia Labs Israel on September 24, 2024 and sell it today you would earn a total of  473,400  from holding Panaxia Labs Israel or generate 24915.79% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Panaxia Labs Israel  vs.  Direct Capital Investments

Panaxia Labs Israel

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Panaxia Labs Israel has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Panaxia Labs is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Direct Capital Inves

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Direct Capital Investments has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's forward indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Panaxia Labs and Direct Capital

The main advantage of trading using opposite Panaxia Labs and Direct Capital positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Panaxia Labs position performs unexpectedly, Direct Capital can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Direct Capital will offset losses from the drop in Direct Capital's long position.

The idea behind Panaxia Labs Israel and Direct Capital Investments pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.